Ozone infiltration as an adjunctive treatment to piezoelectric surgery in the management of medication-related osteonecrosis of the jaws: case series of 29 patients

被引:1
作者
Goker, Funda [1 ,2 ]
Donati, Girolamo [3 ]
Gallo, Francesco
Sparaco, Antonella [3 ]
Rania, Vito [3 ]
Busa, Alberto [3 ]
Grecchi, Francesco [4 ,5 ]
Grecchi, Emma [5 ]
Colapinto, Gianluca [6 ]
Del Fabbro, Massimo [1 ,2 ]
机构
[1] Univ Milan, Dept Biomed Surg & Dent Sci, Milan, MI, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Milan, Italy
[3] ASST Fatebenefratelli Sacco Hosp, Dent Dept, Via Giovanni Battista Grassi 74, Milan, Italy
[4] Ist Stomatol Italiano Milano, Via Pace 21, I-20122 Milan, Italy
[5] Via G Boccaccio 34, I-20123 Milan, Italy
[6] Oral Med Care Srl, Bitonto, Bari, Italy
来源
ORAL AND MAXILLOFACIAL SURGERY-HEIDELBERG | 2024年 / 28卷 / 03期
关键词
MRONJ; MRONJ treatment; Ozone therapy; Piezoelectric surgery; Oxygen therapy; BISPHOSPHONATE-RELATED OSTEONECROSIS; THERAPY; BRONJ;
D O I
10.1007/s10006-024-01246-x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
PurposeMedication-related osteonecrosis of the jaws has been reported to be associated with bisphosphonate and RANKL inhibitor medications. This prospective clinical study aimed to assess the outcomes of pre-operative ozone infiltration therapy in patients with established MRONJ.MethodsThe treatment protocol for ozone applications were designed as 20 applications ozone infiltration therapy followed by surgical interventions of necrotic tissue debridement using piezoelectric surgery instruments. The evaluation of the results based on the clinical and radiologic specifications considering the necrotic lesion reduction and healing. The study included 31 lesions in 29 patients. The mean follow-up was 23.6 months.Results25 lesions out of 31 healed totally without any remissions. The outcomes were not affected by any variables such as gender, age, type of pharmacological treatment, lesion location, and MRONJ staging. The statistically significant results were found among the clinical condition of the patients (p = 0.01) and administration route of medications (p = 0.004). Healing was significantly less in patients that received intra-vascular administrations. Clinical conditions of the patients were divided as osteoporosis, oncologic, and arthritis. Significantly better results were obtained in osteoporosis patients. 38% of the population experienced spontaneous sequestration with signs of improvements and the surgical interventions were canceled. According to the results, total healing of MRONJ lesions was seen in 79% patients (81% lesions).ConclusionOzone therapy and debridement with Piezoelectric surgery can be considered as a safe and beneficial adjunctive treatment alternative for osteonecrosis lesions in cases of established MRONJ.
引用
收藏
页码:1197 / 1207
页数:11
相关论文
共 30 条
  • [1] Agrillo A, 2012, EUR REV MED PHARMACO, V16, P1741
  • [2] Ozone therapy in extractive surgery on patients treated with bisphosphonates
    Agrillo, Alessandro
    Sassano, Pierpaolo
    Rinna, Claudio
    Priore, Paolo
    Iannetti, Giorgio
    [J]. JOURNAL OF CRANIOFACIAL SURGERY, 2007, 18 (05) : 1068 - 1070
  • [3] New therapeutic protocol in the treatment of avascular necrosis of the jaws
    Agrillo, Alessandro
    Petrucci, Maria Teresa
    Tedaldi, Massimiliano
    Mustazza, Maria Cristina
    Marino, Simone Maria Faustino
    Gallucci, Cristiano
    Iannetti, Giorgio
    [J]. JOURNAL OF CRANIOFACIAL SURGERY, 2006, 17 (06) : 1080 - 1083
  • [4] The effects of ozone application on genotoxic damage and wound healing in bisphosphonate-applied human gingival fibroblast cells
    Akdeniz, Sidika Sinem
    Beyler, E.
    Korkmaz, Y.
    Yurtcu, E.
    Ates, U.
    Araz, K.
    Sahin, F. I.
    Torun, O. Y.
    [J]. CLINICAL ORAL INVESTIGATIONS, 2018, 22 (02) : 867 - 873
  • [5] Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS
    Anastasilakis, Athanasios D.
    Pepe, Jessica
    Napoli, Nicola
    Palermo, Andrea
    Magopoulos, Christos
    Khan, Aliya A.
    Zillikens, M. Carola
    Body, Jean-Jacques
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (05) : 1441 - 1460
  • [6] Interventions for managing medication-related osteonecrosis of the jaw
    Beth-Tasdogan, Natalie H.
    Mayer, Benjamin
    Hussein, Heba
    Zolk, Oliver
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (10):
  • [7] COULD OZONE TREATMENT BE A PROMISING ALTERNATIVE FOR OSTEOMYELITIS? AN EXPERIMENTAL STUDY
    Bilge, Ali
    Ozturk, Omur
    Adali, Yasemen
    Ustebay, Sefer
    [J]. ACTA ORTOPEDICA BRASILEIRA, 2018, 26 (01): : 67 - 71
  • [8] Bocci V, 1999, BRIT J BIOMED SCI, V56, P270
  • [9] Worsening of osteonecrosis of the jaw during treatment with sunitinib in a patient with metastatic renal cell carcinoma
    Brunello, Antonella
    Saia, Giorgia
    Bedogni, Alberto
    Scaglione, Daniela
    Basso, Umberto
    [J]. BONE, 2009, 44 (01) : 173 - 175
  • [10] Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020
    Campisi, Giuseppina
    Mauceri, Rodolfo
    Bertoldo, Francesco
    Bettini, Giordana
    Biasotto, Matteo
    Colella, Giuseppe
    Consolo, Ugo
    Di Fede, Olga
    Favia, Gianfranco
    Fusco, Vittorio
    Gabriele, Mario
    Lo Casto, Antonio
    Lo Muzio, Lorenzo
    Marciano, Antonia
    Mascitti, Marco
    Meleti, Marco
    Mignogna, Michele D.
    Oteri, Giacomo
    Panzarella, Vera
    Romeo, Umberto
    Santarelli, Andrea
    Vescovi, Paolo
    Marchetti, Claudio
    Bedogni, Alberto
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (16) : 1 - 15